ABSTRACT
Synthesis, in vitro anti-HIV activity, stability studies as well as potential for oral absorption of some novel phenyl S-acyl-2-thioethyl (SATE) phosphotriester derivatives of AZT (zidovudine; 3'-azido-2',3'- dideoxythymidine) are reported herein. These mononucleotide prodrugs (pronucleotides) are characterized by the presence of polar (amino or hydroxyl) functions on the SATE biolabile phosphate protections. Whereas pronucleotides incorporating an amino residue in the vicinity of the thioester functionality display low chemical stability, the introduction of one or two hydroxyl groups on the SATE moiety confers high resistance of the resulting prodrugs towards esterase hydrolysis. Thus, one of these pronucleotides, derivative 2, was able to cross a Caco-2 cell monolayer mainly in intact form, probing that its further development is warranted as a possible HIV-pronucleotide candidate.
Subject(s)
Anti-HIV Agents/chemistry , Prodrugs/chemistry , Zidovudine/analogs & derivatives , Anti-HIV Agents/metabolism , Anti-HIV Agents/pharmacology , Biological Transport, Active , Caco-2 Cells , Cell Line , HIV-1/drug effects , HIV-1/physiology , Half-Life , Humans , Prodrugs/metabolism , Prodrugs/pharmacology , Pyrimidine Nucleotides/chemistry , Pyrimidine Nucleotides/metabolism , Pyrimidine Nucleotides/pharmacology , Virus ReplicationABSTRACT
A stereospecific HPLC methodology has been developed for the diastereoisomeric resolution of a mononucleotide prodrug in cell extracts. This method involves the use of solid phase extraction on a C18 cartridge. Diastereoisomers and internal standard resolutions were performed on a cellulose based chiral column (Chiralcel OD-H) used in the normal phase mode. The method was validated in terms of specificity, recovery, linearity (diasteroisomers mixture concentration: 3-60 micromol L(-1)), precision and accuracy and detection limit (1.67 and 1.33 micromol L(-1) for first and second eluted diastereoisomer). This method was applied to the determination of the apparent rate constants of disappearance and half-lives of each stereoisomers. This permits to conclude to the stereoselectivity of the enzymatic activity involved in the decomposition pathway of 2.
Subject(s)
Chromatography, High Pressure Liquid/methods , Prodrugs/analysis , Zidovudine/analogs & derivatives , Zidovudine/analysis , Cell Line, Tumor , Humans , Kinetics , Reference Standards , Reproducibility of Results , Sensitivity and Specificity , StereoisomerismABSTRACT
Analytical HPLC methods using derivatized cellulose and amylose chiral stationary phases used in normal and reversed-phase modes were developed for the diastereoisomeric separation of mononucleotide prodrugs (pronucleotides) of 3'-azido-2',3'-dideoxythymidine (AZT). The resolutions were performed with two silica-based celluloses using normal and reversed-phase methodologies: Tris-3,5-dimethylphenylcarbamate (Chiralcel OD-H and Chiracel OD-RH) and Tris-methylbenzoate (Chiralcel OJ and OJ-R). Two amyloses phases, Tris-3,5-dimethylphenylcarbamate (Chiralpak AD) and Tris-(S)-1-phenylethylcarbamate (Chiralpak AS), were used in normal-phase mode. Additionally, we developed separation using two stationary phases with immobilized cyclodextrins in reversed-phase and polar-organic modes. The mobile phase and the chiral stationary phase were varied to achieve the best resolution. Different types and concentration of aliphatic alcohols, acetonitrile or water in the mobile phase were also tested for the different separation modes. An optimal baseline separation (Rs > 1.5) was readily obtained with all silica-based celluloses and amyloses using a normal-phase methodology. The different columns gave complementary results in term of resolution. Limits of detection and quantification were 0.12-0.20 and 0.40-0.67 microm, respectively. This analytical method was applied in a preliminary study for the pronucleotide 2 quantification in cellular extract.
Subject(s)
Chromatography, High Pressure Liquid/instrumentation , Nucleotides/isolation & purification , Prodrugs/isolation & purification , Zidovudine/analogs & derivatives , Amylose/analogs & derivatives , Benzoates , Carbamates , Cell Line, Tumor , Cellulose/analogs & derivatives , Chromatography, High Pressure Liquid/methods , Dideoxynucleotides , Humans , Lymphocytes/chemistry , Lymphocytes/metabolism , Organophosphates/isolation & purification , Phenylcarbamates , Sensitivity and Specificity , Stereoisomerism , Zidovudine/chemistry , Zidovudine/isolation & purification , beta-CyclodextrinsABSTRACT
The in vitro anti-HIV activity, stability, and potential for oral absorption of a phosphotriester derivative of AZT (zidovudine; 3'-azido-2',3'-deoxythymidine) bearing a new esterase-labile S-acyl-2-thioethyl (SATE) group as transient phosphate protection are reported. The biolabile protection is characterized by the presence of a hydroxyl function in the acyl chain. In accordance with previously reported data in the bis(SATE) prodrug series, the present results demonstrate that the studied bis(hydroxytBuSATE)phosphotriester exerts its biological effects via intracellular delivery of the 5'-monophosphate of AZT. The hydroxyl function confers a high resistance against esterase hydrolysis, and the studied prodrug is able to cross the Caco-2 cell monolayers in intact form, suggesting that its further development as a possible anti-HIV pronucleotide candidate is warranted.
